I'm a neuroscientist — the ‘genuinely terrible' research that scares me the most about caffeine
'Caffeine in the neuroscience literature is genuinely terrible when combined with other drugs,' warned Dr. Natashia Swalve, a behavioral neuroscience professor at Grand Valley State University, in a recent TikTok.
One drug in particular has her especially alarmed, with early research suggesting it may pose hazardous risks when mixed with even small amounts of the stimulant.
Advertisement
5 Coffee is the most common source of caffeine for US adults.
Izabela Magier – stock.adobe.com
Roughly 90% of US adults consume some form of caffeine daily. The natural stimulant revs up the central nervous system, boosting alertness, focus and energy levels.
The FDA considers up to 400 milligrams a day — about four or five 8-ounce cups of coffee — safe for healthy adults.
Advertisement
But that safety threshold flies out the window when caffeine starts interacting with other drugs in your system.
'Caffeine actually increases the toxicity of blow, and it potentially increases the toxicity of ADHD meds,' Swalve said. 'When combined with molly, it is particularly dangerous.'
5 Molly acts as both a stimulant and hallucinogen.
blackday – stock.adobe.com
Advertisement
Molly — also known as MDMA or ecstasy — is a synthetic psychoactive drug that floods the brain with serotonin, dopamine and norepinephrine, triggering euphoria, sharpened senses, increased sociability and a rush of energy.
In recent years, MDMA has gained attention as a potential therapeutic tool, but it's still widely used recreationally at music festivals, nightclubs, raves and house parties.
National surveys estimate that 7.5% of Americans over the age of 12 have tried molly at least once.
But the feel-good high comes at a cost. The drug can bring on a host of adverse effects, including rapid heartbeat, muscle cramping and nausea.
Advertisement
It also disrupts the body's ability to regulate temperature — essentially cranking up its internal thermostat — which can lead to a dangerous and sometimes fatal condition known as hyperthermia.
5 Consuming molly raises your core body temperature — and caffeine can intensify the effect.
dragonstock – stock.adobe.com
'In animal and cell studies, caffeine makes the hyperthermic effect of molly … far worse,' Swalve said.
While caffeine alone doesn't typically affect body temperature, research in rats shows that combining it with MDMA significantly increases both the peak temperature and the duration of the hyperthermic response — making users much more vulnerable to overheating.
'Caffeine also can increase the other problematic effects of molly,' Swalve said. 'It can actually make the drug more neurotoxic, killing off those serotonin neurons in your brain.'
Serotonin plays a wide range of important roles in the body, supporting mood, sleep, digestion, appetite and even blood clotting and wound healing.
Animal studies show MDMA has the potential to inflict long-term damage on serotonin neurons, which may lead to memory issues, cognitive decline and mood disorders.
Advertisement
5 Caffeine amplifies the effects of molly, potentially leading to dangerously high serotonin levels.
Anusorn – stock.adobe.com
'Caffeine combined with molly might be even worse for those neurons, but the problem is that none of these studies have actually been translated into humans,' Swalve said.
And it doesn't take much to trigger the reaction.
Swalve notes that the interaction between caffeine and molly can occur at very low doses — like the amount in a chocolate bar or a third of a can of Coke.
Advertisement
'We think these things might interact in very dangerous ways, but we can't actually really tell,' she said. 'Right now we have no research in humans, and that is what actually scares me.'
Other potential risks of combining molly and caffeine include an increased risk of cardiovascular issues, depression, anxiety and serotonin syndrome — a life-threatening condition marked by confusion, high fever and a rapid heart rate.
In one study, mixing caffeine with molly increased the party drug's lethality from 22% to 34% in rats.
Advertisement
'This is a huge problem,' Swalve said. 'Barely anyone is thinking about the Red Bull they're having while driving to that festival and how that might interact with the drugs they're taking later.'
5 Molly is one of the most well-known and frequently used club drugs.
Yuri Arcurs/peopleimages.com – stock.adobe.com
Although several studies have looked at caffeine-MDMA interactions in animals and cells, researchers have run into roadblocks when attempting to test the combination in humans.
Among them: molly is considered a Schedule I substance under federal law. These drugs are considered to have a high potential for abuse and no accepted medical use.
Advertisement
That has made it difficult for researchers to not only obtain molly, but also secure the funding and approvals necessary for such studies.
Ethical concerns also come into play. The potential dangers of combining two powerful stimulants raise major red flags about participant safety in clinical trials — and make recruiting test subjects even harder.
So, as scientists work to understand the short- and long-term consequences of mixing caffeine with other drugs, Americans will continue to sip, sniff, smoke and swallow a cocktail of prescription and recreational substances — often with little clue about the risks.
'I can't guarantee that any of those together are safe,' Swalve said. 'You probably are not even considering those interactions.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
FDA Grants Priority Review for Merck & Co's (MRK) WINREVAIR
Merck & Co., Inc. (NYSE:MRK) is one of the . On July 2, Merck & Co., Inc. (NYSE:MRK) announced that the FDA has accepted and granted priority review to its supplemental Biologics License Application for WINREVAIR. Merck & Co., Inc.'s (NYSE:MRK) WINREVAIR was previously approved in 2024 for treating adults with pulmonary arterial hypertension. The treatment aims to increase exercise capacity, improve WHO functional class, and reduce the risk of clinical worsening events. The current application seeks to update the US product label based on the results of the Phase 3 ZENITH trial. A close-up of a person's hand holding a bottle of pharmaceuticals. The ZENITH trial is notable for being the first Phase 3 PAH study to use a primary endpoint focused solely on major morbidity and mortality events. The results demonstrated a 76% reduction in the risk of a composite outcome of all-cause death, lung transplantation, and hospitalization for PAH lasting 24 hours or more, compared to placebo. The FDA has set a target action date of October 25, 2025, under the Prescription Drug User Fee Act. Merck & Co., Inc. (NYSE:MRK) is a leading healthcare company that operates through two main segments including the Pharmaceutical and Animal Health Segments. While we acknowledge the potential of MRK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
New York Post
7 hours ago
- New York Post
How forever chemicals target developing male brains — and what this means for their autism risk
Neurodevelopmental conditions like autism and ADHD disproportionately affect males, with some estimating boys are four times as likely to be diagnosed as girls. Theories suggest this gender gap may be because male brains are more sensitive to changes during development, and girls might be better at hiding the signs or showing them in different ways. Now, a new study published in the European Journal of Neuroscience has uncovered a shocking link between PFAS — also known as 'forever chemicals — and autism in men. Advertisement 3 A new study has uncovered a shocking link between PFAS — also known as 'forever chemicals — and autism in men. mavoimages – Scientists gave pregnant mice a type of short-chain PFAS called PFHxA — a chemical that's still widely used even though it's been restricted in some parts of the world. The mothers were fed small doses, similar to what people might come across in their daily lives, and when their pups grew up, the male mice showed clear changes in behavior. Advertisement They were less active, more anxious and had trouble with memory, while the female mice didn't seem affected at all. 'Although these effects were mild, finding behavioral effects only in males was reminiscent of the many neurodevelopmental disorders that are male-biased,' Ania Majewska, a neuroscience professor at the University of Rochester, said in a press release. 'This finding suggests that the male brain might be more vulnerable to environmental insults during neurodevelopment.' 3 Neurodevelopmental conditions like autism and ADHD disproportionately affect males, with some estimates placing the ratio of boy versus girl diagnoses at 4:1. Vitalii Vodolazskyi – Advertisement Until recently, PFHxA was considered a 'safer' replacement for older, more notorious forever chemicals that have been phased out. But this study suggests we may have just swapped one problem for another — especially when it comes to protecting developing male brains. 'Finding that developmental exposure to PFHxA has long-term behavioral consequences in a mammalian model is concerning when considering short-chain PFAS are thought to be safer alternatives to the legacy PFAS that have been phased-out of production,' study lead author Elizabeth Plunk said. Advertisement 'Understanding the impacts of PFHxA on the developing brain is critical when proposing regulations around this chemical. Hopefully, this is the first of many studies evaluating the neurotoxicity of PFHxA.' 3 There are over 4,700 PFAS, which are used to make items resistant to water, grease and stains. artursfoto – The findings, while done on mice, suggest we need to take a closer scientific look at the link between forever chemicals and autism. 'This work points to the need for more research in short-chain PFAS. To our knowledge, PFHxA has not been evaluated for developmental neurobehavioral toxicity in a rodent model,' said Majewska. ' 'Future studies should evaluate the cellular and molecular effects of PFHxA, including cell-type specific effects, in regions associated with motor, emotional/fear, and memory domains to elucidate mechanistic underpinnings.' PFAS — synthetic substances that persist in the environment and human body — have been likened to 'slow poisons' that may increase the risk of certain cancers, fertility troubles, liver damage and developmental delays in children. Advertisement There are over 4,700 PFAS, which are used to make items resistant to water, grease and stains. They can be found in food packaging, cookware, waterproof clothing, firefighting foam, certain personal care products and — most recently — beer.
Wall Street Journal
7 hours ago
- Wall Street Journal
Medical Risk-Aversion Can Kill, Too
Modern life is a series of trade-offs. We drive cars, fly in planes and use power tools, accepting that while these things carry risk, their benefits far outweigh their potential harm. Roughly 40,000 Americans die each year in motor vehicle accidents, yet no one seriously proposes banning cars. We regulate, we inform, and we improve, but we don't walk away from technologies that make life better. Yet in medicine, especially when it comes to pharmaceuticals and cutting-edge therapies, we seem to forget this logic.
